Neuroprotective effect of(-)Δ9-tetrahydrocannabinol and cannabidiol in N-methyl-D-aspartate-induced retinal neurotoxicity -: Involvement of peroxynitrite

被引:184
作者
El-Remessy, AB
Khalil, IE
Matragoon, S
Abou-Mohamed, G
Tsai, NJ
Roon, P
Caldwell, RB
Caldwell, RW
Green, K
Liou, GI
机构
[1] Med Coll Georgia, Dept Ophthalmol, Augusta, GA 30912 USA
[2] Med Coll Georgia, Dept Pharmacol & Toxicol, Augusta, GA 30912 USA
[3] Med Coll Georgia, Dept Anat & Cellular Biol, Augusta, GA 30912 USA
[4] Med Coll Georgia, Vasc Biol Ctr, Augusta, GA 30912 USA
关键词
D O I
10.1016/S0002-9440(10)63558-4
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
In glaucoma, the increased release of glutamate is the major cause of retinal ganglion cell death. Cannabinoids have been demonstrated to protect neuron cultures from glutamate-induced death. In this study, we test the hypothesis that glutamate causes apoptosis of retinal neurons via the excessive formation of peroxynitrite, and that the neuroprotective effect of the psychotropic Delta9-tetrahydroxycannabinol (THC) or nonpsychotropic cannabidiol (CBD) is via the attenuation of this formation. Excitotoxicity of the retina was induced by intravitreal injection of N-methyl-D-aspartate (NMDA) in rats, which also received 4-hydroxy-2,2,6,6-tetramethylpiperidine-n-oxyl (TEMPOL, a superoxide dismutase-mimetic), N-co-nitro-L-arginine methyl ester (L-NAME, a nitric oxide synthase inhibitor), THC, or CBD. Retinal neuron loss was determined by TDT-mediated dUTP nick-end labeling assay, inner retinal thickness, and quantification of the mRNAs of ganglion cell markers. NMDA induced a dose- and time-dependent accumulation of nitrite/nitrate, lipid peroxidation, and nitrotyrosine (foot print of peroxynitrite), and a dose-dependent apoptosis and loss of inner retinal neurons. Treatment with L-NAME or TEMPOL protected retinal neurons and confirmed the involvement of peroxynitrite in retinal neurotoxicity. The neuroprotection by THC and CBD was because of attenuation of peroxynitrite. The effect of THC was in part mediated by the cannabinoid receptor CB1. These results suggest the potential use of CBD as a novel topical therapy for the treatment of glaucoma.
引用
收藏
页码:1997 / 2008
页数:12
相关论文
共 59 条
[1]  
AYOUB G, 2002, INT CANN RES SOC 12
[2]   LOCALIZATION OF THE THY-1 ANTIGEN TO THE SURFACES OF RAT RETINAL GANGLION-CELLS [J].
BEALE, R ;
OSBORNE, NN .
NEUROCHEMISTRY INTERNATIONAL, 1982, 4 (06) :587-595
[3]   Pharmacology of the intraocular pressure (IOP) lowering effect of systemic dexanabinol (HU-211), a non-psychotropic cannabinoid [J].
Beilin, M ;
Neumann, R ;
Belkin, M ;
Green, K ;
Bar-Ilan, A .
JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS, 2000, 16 (03) :217-230
[4]   Molecular targets for cannabidiol and its synthetic analogues: effect on vanilloid VR1 receptors and on the cellular uptake and enzymatic hydrolysis of anandamide [J].
Bisogno, T ;
Hanus, L ;
De Petrocellis, L ;
Tchilibon, S ;
Ponde, DE ;
Brandi, I ;
Moriello, AS ;
Davis, JB ;
Mechoulam, R ;
Di Marzo, V .
BRITISH JOURNAL OF PHARMACOLOGY, 2001, 134 (04) :845-852
[5]   Glutamine immunoreactivity in Muller cells of monkey eyes with experimental glaucoma [J].
Carter-Dawson, L ;
Shen, F ;
Harwerth, RS ;
Smith, EL ;
Crawford, MLJ ;
Chuang, A .
EXPERIMENTAL EYE RESEARCH, 1998, 66 (05) :537-545
[6]   Modification of 5-HT2 receptor mediated behaviour in the rat by oleamide and the role of cannabinoid receptors [J].
Cheer, JF ;
Cadogan, AK ;
Marsden, CA ;
Fone, KCF ;
Kendall, DA .
NEUROPHARMACOLOGY, 1999, 38 (04) :533-541
[7]  
Ciani E, 1996, BRAIN RES, V728, P1
[8]   OXIDATIVE STRESS, GLUTAMATE, AND NEURODEGENERATIVE DISORDERS [J].
COYLE, JT ;
PUTTFARCKEN, P .
SCIENCE, 1993, 262 (5134) :689-695
[9]   Effects of tempol, a membrane-permeable radical scavenger, in a gerbil model of brain injury [J].
Cuzzocrea, S ;
McDonald, MC ;
Mazzon, E ;
Siriwardena, D ;
Costantino, G ;
Fulia, F ;
Cucinotta, G ;
Gitto, E ;
Cordaro, S ;
Barberi, I ;
De Sarro, A ;
Caputi, AP ;
Thiemermann, C .
BRAIN RESEARCH, 2000, 875 (1-2) :96-106
[10]   Involvement of other neurotransmitters in behaviors induced by the cannabinoid CB1 receptor antagonist SR 141716A in naive mice [J].
Darmani, NA ;
Pandya, DK .
JOURNAL OF NEURAL TRANSMISSION, 2000, 107 (8-9) :931-945